Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen D. Zoller is active.

Publication


Featured researches published by Stephen D. Zoller.


Journal of Shoulder and Elbow Surgery | 2014

Reverse shoulder arthroplasty for acute proximal humerus fractures: a systematic review

Oke A. Anakwenze; Stephen D. Zoller; Christopher S. Ahmad; William N. Levine

BACKGROUND Proximal humerus fractures are one of the most common fractures among elderly patients. We performed a systematic review to detail the demographics, outcomes, and complications of patients who undergo reverse shoulder arthroplasty for complex proximal humerus fractures. METHODS A systematic review of the literature was performed. Two reviewers assessed and confirmed the methodical quality of each study. Studies that met our criteria were assessed for pertinent data, and when available, similar outcomes were combined to generate frequency-weighted means. RESULTS Nine studies met the inclusion and exclusion criteria for this review. The frequency weighted mean age was 77.5 years and the mean follow up was 43.2 months. Females comprised 90.4% of the patient population. Four-part fractures were most commonly encountered. The frequency weighted mean constants score was 55.9. Frequency weighted mean active forward flexion, abduction, and external rotation at neutral were 122°, 97°, and 18°, respectively. Tuberosity repair was associated with significantly higher external rotation compared to no repair (24° vs 15°; P = .0003). The most common complication was scapular notching (32%) while the impact of this finding remains unknown. CONCLUSION Pooled data and frequency weighted mean outcomes showed that RSA patients tend to be elderly women and still have postoperative dysfunction despite well-controlled pain. Repair of the greater tuberosity allows greater range of motion in patients.


Neurosurgical Focus | 2011

Traumatic brain injury in pediatric patients: evidence for the effectiveness of decompressive surgery

Geoffrey Appelboom; Stephen D. Zoller; Matthew Piazza; Caroline Szpalski; Samuel S. Bruce; Michael M. McDowell; Kerry A. Vaughan; Brad E. Zacharia; Zachary L. Hickman; Anthony L. D'Ambrosio; Neil A. Feldstein; Richard C. E. Anderson

Traumatic brain injury (TBI) is the current leading cause of death in children over 1 year of age. Adequate management and care of pediatric patients is critical to ensure the best functional outcome in this population. In their controversial trial, Cooper et al. concluded that decompressive craniectomy following TBI did not improve clinical outcome of the analyzed adult population. While the study did not target pediatric populations, the results do raise important and timely clinical questions regarding the effectiveness of decompressive surgery in pediatric patients. There is still a paucity of evidence regarding the effectiveness of this therapy in a pediatric population, and there is an especially noticeable knowledge gap surrounding age-stratified interventions in pediatric trauma. The purposes of this review are to first explore the anatomical variations between pediatric and adult populations in the setting of TBI. Second, the authors assess how these differences between adult and pediatric populations could translate into differences in the impact of decompressive surgery following TBI.


Protist | 2012

Characterization and taxonomic validity of the ciliate Oxytricha trifallax (Class Spirotrichea) based on multiple gene sequences: limitations in identifying genera solely by morphology.

Stephen D. Zoller; Robert L. Hammersmith; Estienne C. Swart; Brian P. Higgins; Thomas G. Doak; Glenn Herrick; Laura F. Landweber

Oxytricha trifallax - an established model organism for studying genome rearrangements, chromosome structure, scrambled genes, RNA-mediated epigenetic inheritance, and other phenomena - has been the subject of a nomenclature controversy for several years. Originally isolated as a sibling species of O. fallax, O. trifallax was reclassified in 1999 as Sterkiella histriomuscorum, a previously identified species, based on morphological similarity. The proper identification of O. trifallax is crucial to resolve in order to prevent confusion in both the comparative genomics and the general scientific communities. We analyzed nine conserved nuclear gene sequences between the two given species and several related ciliates. Phylogenetic analyses suggest that O. trifallax and a bona fide S. histriomuscorum have accumulated significant evolutionary divergence from each other relative to other ciliates such that they should be unequivocally classified as separate species. We also describe the original isolation of O. trifallax, including its comparison to O. fallax, and we provide criteria to identify future isolates of O. trifallax.


Current Reviews in Musculoskeletal Medicine | 2016

Current management of aneurysmal bone cysts

Howard Y. Park; Sara K. Yang; William L. Sheppard; Vishal Hegde; Stephen D. Zoller; Scott D. Nelson; Noah Federman; Nicholas M. Bernthal

Aneurysmal bone cysts (ABCs) are benign bone lesions arising predominantly in the pediatric population that can cause local pain, swelling, and pathologic fracture. Primary lesions, which constitute roughly two thirds of all ABCs, are thought to be neoplastic in nature, with one third of ABCs arising secondary to other tumors. Diagnosis is made with various imaging modalities, which exhibit characteristic features such as “fluid-fluid levels,” although biopsy is critical, as telangiectatic osteosarcoma cannot be excluded based on imaging alone. Currently, the standard of care and most widely employed treatment is intralesional curettage. However, tumor recurrence with curettage alone is common and has driven some to propose a multitude of adjuvants with varying efficacy and risk profiles. Historically, therapies such as en bloc resection or radiation therapy were utilized as an alternative to decrease the recurrence rate, but these therapies imposed high morbidity. As a result, modern techniques now seek to simultaneously reduce morbidity and recurrence, the pursuit of which has produced preliminary study into minimally invasive percutaneous treatments and medical management.


Neurological Research | 2012

Variation in a locus linked to platelet aggregation phenotype predicts intraparenchymal hemorrhagic volume

Geoffrey Appelboom; Matthew Piazza; Samuel S. Bruce; Stephen D. Zoller; Brian Y. Hwang; Aimee Monahan; Richard Y. Hwang; Sergey Kisslev; Stephan A. Mayer; Philip M. Meyers; Neeraj Badjatia; E. Sander Connolly

Abstract Objective: Alteration in platelet aggregation has been shown to promote bleeding and affect outcome after intracerebral hemorrhage (ICH).We investigated the influence of genetic variants of platelet aggregation, and their effects on admission ICH volume and clinical outcome. Methods: Our prospective study analyzed selected candidate single-nucleotide polymorphisms (SNPs) previously associated with platelet aggregation phenotype in previous genome-wide association studies, with regards to outcome and ICH volume. Patients were assessed at the Columbia University Medical Center Neuro-Intensive Care Unit. Exclusion criteria included age <18 years, ICH following trauma, hemorrhagic transformation, or tumor, no consent for genetic analysis, or incomplete data. Radiological variables (location and volume of acute ICH, presence of intraventricular extension, midline shift, and hydrocephalus) and clinical variables (mortality and modified Rankin score at discharge) were prospectively recorded. Results: One hundred and twenty-two patients with spontaneous ICH between February 2009 and May 2011 diagnosed via clinical assessment and admission computed tomography scan were included. The median admission Glasgow coma scale score (GCS) was 11·5. Univariate predictors of mortality at discharge included systolic blood pressure, presence of intraventricular hemorrhage, anticoagulant use, and GCS, the only independent predictor of discharge mortality (P<0·001). Age, intraventricular hemorrhage, and GCS were associated with poor functional outcome; age (P = 0·001) and GCS (P<0·001) were significant in the multivariate model. Admission GCS (P<0·01), antiplatelet use, and rs342286 (PIK3CG; P = 0·04; R2 = 0·247) had univariate associations with hematoma volume. Discussion: We identified SNP rs342286 as an independent predictor of admission hematoma volume. Our findings suggest that PIK3CG function, which is previously linked to this SNP and affects platelet aggregation, impacts the severity of the intraparenchymal bleed.


Spine | 2017

Intraoperative Neuromonitoring for Anterior Cervical Spine Surgery: What is the Evidence?

Remi M. Ajiboye; Stephen D. Zoller; Akshay Sharma; Gina M. Mosich; Austin Drysch; Jesse Li; Tara Reza; Sina Pourtaheri

Study Design. Systematic review and meta-analysis. Objective. The goal of this study was to (i) assess the risk of neurological injury after anterior cervical spine surgery (ACSS) with and without intraoperative neuromonitoring (ION) and (ii) evaluate differences in the sensitivity and specificity of ION for ACSS. Summary of Background Data. Although ION is used to detect impending neurological injuries in deformity surgery, its utility in ACSS remains controversial. Methods. A systematic search of multiple medical reference databases was conducted for studies on ION use for ACSS. Studies that included posterior cervical surgery were excluded. Meta-analysis was performed using the random-effects model for heterogeneity. Outcome measure was postoperative neurological injury. Results. The search yielded 10 studies totaling 26,357 patients. The weighted risk of neurological injury after ACSS was 0.64% (0.23–1.25). The weighted risk of neurological injury was 0.20% (0.05–0.47) for ACDFs compared with 1.02% (0.10–2.88) for corpectomies. For ACDFs, there was no difference in the risk of neurological injury with or without ION (odds ratio, 0.726; confidence interval, CI, 0.287–1.833; P = 0.498). The pooled sensitivities and specificities of ION for ACSS are 71% (CI: 48%–87%) and 98% (CI: 92%–100%), respectively. Unimodal ION has a higher specificity than multimodal ION [unimodal: 99% (CI: 97%–100%), multimodal: 92% (CI: 81%–96%), P = 0.0218]. There was no statistically significant difference in sensitivities between unimodal and multimodal [68% vs. 88%, respectively, P = 0.949]. Conclusion. The risk of neurological injury after ACSS is low although procedures involving a corpectomy may carry a higher risk. For ACDFs, there is no difference in the risk of neurological injury with or without ION use. Unimodal ION has a higher specificity than multimodal ION and may minimize “subclinical” intraoperative alerts in ACSS. Level of Evidence: 3


PLOS ONE | 2017

Combinatory antibiotic therapy increases rate of bacterial kill but not final outcome in a novel mouse model of Staphylococcus aureus spinal implant infection

Yan Hu; Vishal Hegde; Daniel Johansen; Amanda H. Loftin; Erik M. Dworsky; Stephen D. Zoller; Howard Y. Park; Christopher D. Hamad; George E. Nelson; Kevin P. Francis; Anthony A. Scaduto; Nicholas M. Bernthal

Background Management of spine implant infections (SII) are challenging. Explantation of infected spinal hardware can destabilize the spine, but retention can lead to cord compromise and biofilm formation, complicating management. While vancomycin monotherapy is commonly used, in vitro studies have shown reduced efficacy against biofilm compared to combination therapy with rifampin. Using an established in vivo mouse model of SII, we aim to evaluate whether combination therapy has increased efficacy compared to both vancomycin alone and infected controls. Methods An L-shaped, Kirschner-wire was transfixed into the L4 spinous process of 12-week-old C57BL/6 mice, and inoculated with bioluminescent Staphylococcus aureus. Mice were randomized into a vancomycin group, a combination group with vancomycin plus rifampin, or a control group receiving saline. Treatment began on post-operative day (POD) 7 and continued through POD 14. In vivo imaging was performed to monitor bioluminescence for 35 days. Colony-forming units (CFUs) were cultured on POD 35. Results Bioluminescence peaked around POD 7 for all groups. The combination group had a 10-fold decrease in signal by POD 10. The vancomycin and control groups reached similar levels on POD 17 and 21, respectively. On POD 25 the combination group dropped below baseline, but rebounded to the same level as the other groups, demonstrating a biofilm-associated infection by POD 35. Quantification of CFUs on POD 35 confirmed an ongoing infection in all three groups. Conclusions Although both therapies were initially effective, they were not able to eliminate implant biofilm bacteria, resulting in a rebound infection after antibiotic cessation. This model shows, for the first time, why histologic-based, static assessments of antimicrobials can be misleading, and the importance of longitudinal tracking of infection. Future studies can use this model to test combinations of antibiotic therapies to see if they are more effective in eliminating biofilm prior to human trials.


The International Journal of Spine Surgery | 2017

Regression of Disc-Osteophyte Complexes Following Laminoplasty Versus Laminectomy with Fusion for Cervical Spondylotic Myelopathy

Remi M. Ajiboye; Stephen D. Zoller; Adedayo A. Ashana; Akshay Sharma; William L. Sheppard; Langston T. Holly

Background Laminectomy with fusion (LF) and laminoplasty are two posterior-based surgical approaches for the surgical treatment of cervical spondylotic myelopathy (CSM). The decompressive effect of these approaches is thought to be primarily related to the dorsal drift of the spinal cord away from ventral compressive structures. A lesser known mechanism of spinal cord decompression following cervical LF is regression of the ventral disc osteophyte complexes which is postulated to result from the alteration of motion across the fused motion segment. The goal of this study was to determine whether regression of the ventral disc-osteophyte complexes occur following laminoplasty and compare the magnitude of this occurrence to cervical laminectomy and fusion. Methods Seventy patients with CSM who underwent pre- and postoperative magnetic resonance imaging (MRI) and were treated with either laminoplasty or LF. The size of the disc-osteophyte complex at all operative levels were measured on pre- and postoperative MRI using digital calipers. Results The laminoplasty group consisted of 25 patients with an average age of 54.9 and a mean of 3.24 surgical levels while the LF group consisted of 45 patients with an average age of 65.4 and a mean of 3.44 surgical levels (age, p < 0.0001; levels, p= 0.46). The average time interval between pre- and post-operative MRI was 16.2 and 15.6 months in the laminoplasty and LF groups, respectively (p = 0.91). The average time interval between surgery and post-operative MRI was 10.1 and 10.7 months in the laminoplasty and LF groups, respectively (p = 0.86). When comparing pre- and post-operative MRI, there was a 9.59% decrease in disc-osteophyte complex size from 3.84mm ± 0.74 to 3.47mm ± 0.86 in the laminoplasty group compared to a 35.4% decrease in disc-osteophyte complex size from 4.60mm ± 1.06 to 2.98mm ± 1.33 in LF group (laminoplasty, p < 0.0001; LF, p = 0.0067). Using logistic regression analysis, LF, increased time interval between surgery and post-operative MRI, high cobb angle, and straight sagittal alignment were all independently associated with increased disc-osteophyte complex regression (p < 0.05). No differences in functional outcomes (as defined by mJOA scores) was found between the two surgical techniques. Conclusions In patients with CSM that had a posterior surgical approach, LF is associated with a larger interval regression in disc-osteophyte complex size compared to laminoplasty. This is likely related to the loss of motion of the cervical spine after surgery as governed by Wolff’s law and the Heuter-Volkmann’s principle. Although the decompressive effect of LF and laminoplasty is primarily related to the dorsal drift of the spinal cord away from ventral compressive structures, disc-osteophyte complex regression likely provides another mechanism of spinal cord decompression.


Journal of Surgical Oncology | 2018

Long-term outcomes of cement in cement technique for revision endoprosthesis surgery

Nicholas M. Bernthal; Vishal Hegde; Stephen D. Zoller; Howard Y. Park; Jason H. Ghodasra; Daniel Johansen; Frederick R. Eilber; Fritz C. Eilber; Chandhanarat Chandhanayingyong; Jeffrey J. Eckardt

Cemented endoprosthetic reconstruction after resection of primary bone sarcomas has been a standard‐of‐care option for decades. With increased patient survival, the incidence of failed endoprostheses requiring revision surgery has increased. Revision of cemented endoprotheses by cementing into the existing cement mantle (CiC) is technically demanding.


Clinical Orthopaedics and Related Research | 2018

Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors

Vishal Hegde; Zachary D. C. Burke; Howard Y. Park; Stephen D. Zoller; Daniel Johansen; Benjamin V. Kelley; Ben Levine; Kambiz Motamedi; Noah Federman; Leanne L. Seeger; Scott D. Nelson; Nicholas M. Bernthal

Background Although there is widespread acceptance of core needle biopsy (CNB) for diagnosing solid tumors, there is reluctance by some clinicians to use CNB for aneurysmal bone cysts (ABCs) as a result of concerns of safety (bleeding, nerve injury, fracture, readmission, or infection) and reliability, particularly to rule out malignant diagnoses like telangiectatic osteosarcoma. This is especially true when CNB tissue is sent from an outside hospital, where the technique used to obtain the tissue may be spurious. Questions/purposes (1) Is CNB effective (provided adequate information to indicate appropriate surgical treatment without further open biopsy) as an initial diagnostic test for ABC? (2) Is CNB accurate (pathology consistent with the subsequent definitive surgical pathologic diagnosis) in differentiating between benign lesions such as primary or secondary ABCs and malignant radiolucent lesions such as telangiectatic osteosarcoma? (3) What are the complications of CNB? (4) Is there any difference in the effectiveness or accuracy of CNB performed at outside institutions when compared with a referral center? Methods A retrospective study of our musculoskeletal tumor board pathology database (1990-2016) was performed using search criteria “aneurysmal bone cyst” or “telangiectatic osteosarcoma.” Only patients undergoing a CNB who proceeded to definitive surgical resection with final pathology were included. Excluding outside CNBs, CNB was performed after presentation at a musculoskeletal tumor board as a result of atypical features on imaging or history concerning for malignancy. Outside CNB tissue was reviewed by our pathologists. If there was sufficient tissue for diagnosis, the patient proceeded to definitive surgery. If not, the patient underwent open biopsy. CNB diagnosis, open biopsy results, and open surgical resection pathology were reviewed. Complications, including bleeding, infection, nerve injury, readmission, or fracture, between the CNB and definitive open surgical procedure (mean 1.6 months) were documented. CNBs were considered “effective” if they yielded pathology considered sufficient to proceed with appropriate definitive surgery without additional open biopsy. CNBs were considered “accurate” if they were effective and yielded a pathologic diagnosis that matched the subsequent definitive surgical pathology. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of obtaining a malignant diagnosis using CNB were also calculated. Results A total of 81% (59 of 73) of CNBs were effective. Ninety-three percent (55 of 59) of CNBs were classified as accurate. Diagnostic CNBs had a sensitivity and specificity of 89% (eight of nine) and 100% (51 of 51), respectively. The PPV was 1.00 and the NPV was 0.82. There were no complications. With the numbers available, there was no difference in efficacy (90% [37 of 41 versus 14 of 15]; odds ratio, 0.97 [95% confidence interval {CI}, 0.41-2.27], p = 0.94) or accuracy (92% [34 of 37 versus 13 of 14]; odds ratio, 0.87 [95% CI, 0.08-9.16], p = 0.91) between CNBs performed in house and those referred from outside. Conclusions These data suggest that CNBs are useful as an initial diagnostic test for ABC and telangiectatic osteosarcoma. Tissue from outside CNBs can be read reliably without repeat biopsy. If confirmed by other institutions, CNB may be considered a reasonable approach to the diagnosis of aggressive, radiolucent lesions of bone. Level of Evidence Level III, diagnostic study.

Collaboration


Dive into the Stephen D. Zoller's collaboration.

Top Co-Authors

Avatar

Howard Y. Park

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vishal Hegde

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ryan Smith

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge